Evidence map›Paper›PMID 38468040›Full record

ReviewAdvances in neurobiology2024

Fractal Dimension Analysis in Neurological Disorders: An Overview.

Leticia Díaz Beltrán, Christopher R Madan, Carsten Finke, Stephan Krohn, Antonio Di Ieva, Francisco J Esteban

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
47.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Computational Fractal-Based Neurosurgery.Advances in experimental medicine and biology · 2024
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 4 countries.

Leticia Díaz BeltránDepartment of Medical Oncology, Clinical Research Unit, University Hospital of Jaén, Jaén, Spain.
Christopher R MadanSchool of Psychology, University of Nottingham, Nottingham, UK.
Carsten FinkeDepartment of Neurology, Charité-Universitätsmedizin, Berlin, Germany.
Stephan KrohnDepartment of Neurology, Charité-Universitätsmedizin, Berlin, Germany.
Antonio Di IevaComputational NeuroSurgery (CNS) Lab, Faculty of Medicine, Health and Human Sciences, Macquarie Medical School, Macquarie University, Sydney, NSW, Australia.
Francisco J EstebanSystems Biology Unit, Department of Experimental Biology, University of Jaén, Jaén, Spain. festeban@ujaen.es.
Charité - Universitätsmedizin Berlin · DEComplejo Hospitalario de Jaén · ESMacquarie University · AUUniversidad de Jaén · ESUniversity of Nottingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fractal analysis has emerged as a powerful tool for characterizing irregular and complex patterns found in the nervous system. This characterization is typically applied by estimating the fractal dimension (FD), a scalar index that describes the topological complexity of the irregular components of the nervous system, both at the macroscopic and microscopic levels, that may be viewed as geometric fractals. Moreover, temporal properties of neurophysiological signals can also be interpreted as dynamic fractals. Given its sensitivity for detecting changes in brain morphology, FD has been explored as a clinically relevant marker of brain damage in several neuropsychiatric conditions as well as in normal and pathological cerebral aging. In this sense, evidence is accumulating for decreases in FD in Alzheimer's disease, frontotemporal dementia, Parkinson's disease, multiple sclerosis, and many other neurological disorders. In addition, it is becoming increasingly clear that fractal analysis in the field of clinical neurology opens the possibility of detecting structural alterations in the early stages of the disease, which highlights FD as a potential diagnostic and prognostic tool in clinical practice.

Indexed as

Alzheimer DiseaseFrontotemporal DementiaAgingFractalsHumansPrognosisBrain tumorsClinical neurologyCognitionComplex systemsFractal dimension

Identifiers

PMID38468040
OpenAlexW4392720141

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.